Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 260 participants.
Also called NCT07585968
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 260 participants
- Registry
-
NCT07585968
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07585968. Allocation not applicable; no masking; primary purpose treatment. Start 2026-08-17 (actual); primary completion 2028-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
- Condition
- Ventricular Tachycardia
- Intervention (Device)
- Sphere-9 Catheter with the Affera Mapping and Ablation System
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
Record details
- Record id
cardio:ct-nct07585968- Content hash
269a9811404eb022ed9cdee35cfed99d150c1ae0f6e905796c38769aa9adbe0a